Cargando…
Rationale and clinical utility of the darunavir–cobicistat combination in the treatment of HIV/AIDS
This article is to provide an update overview of cobicistat (COBI)-boosted darunavir in response to its recent approval by the US Food and Drug Administration, and inclusion as an alternative first-line regime in the 2015 treatment guidelines in the US. COBI is a relatively new non-antiretroviral cy...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627402/ https://www.ncbi.nlm.nih.gov/pubmed/26566368 http://dx.doi.org/10.2147/DDDT.S63989 |